CARLIE FREDERICK: Open Payments
NPI 1497984603 · COLUMBUS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$755 in 33 payments from 14 companies in 2025. Trend: 2023 $519 · 2024 $700 · 2025 $755
Food & beverage: $755
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 1 | $100 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $96 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $79 |
| Teva Pharmaceuticals USA, Inc. | 4 | $76 |
| Alkermes, Inc. | 4 | $73 |
| E.R. Squibb & Sons, L.L.C. | 4 | $72 |
| Lundbeck LLC | 3 | $69 |
| Janssen Pharmaceuticals, Inc | 2 | $58 |
| Axsome Therapeutics, Inc. | 1 | $30 |
| Vanda Pharmaceuticals Inc. | 1 | $25 |
Products named: ZURZUVAE, CAPLYTA, TRINTELLIX, AUSTEDO XR, ARISTADA, COBENFY, REXULTI, SPRAVATO.
Industry payments across GA — which companies pay providers there.
